Picture [iito] Männer Ballett 650x80px
Organisation › Details

TC BioPharm Ltd. (TCB)

TC BioPharm (TCB) is an immunotherapy company developing novel cell based products for treatment of cancer and severe viral infections. TC BioPharm is working with clinical centres of excellence to treat cancer patients in Glasgow, Edinburgh, Oxford, Southampton, London, Leeds, Cardiff, Manchester, Sheffield and Belfast. The company has raised over €25million in funding since commencing operations in February 2014. It has premises in Glasgow, Edinburgh and London, employing over 50 members of staff. *


Period Start 2014-03-11 existent
Products Industry cell therapy
  Industry 2 cancer immunotherapy (immuno-oncology, I-O)
Person Person Leek, Michael (TC BioPharm 201501 Chief Executive)
  Street Bush Loan
Pentlands Science Park
  City EH26 0PZ Penicuik, Midlothian
    Address record changed: 2014-03-11
Basic data Employees B: 11 to 50 (2017-08-02)
    * Document for �About Section�: TC BioPharm Ltd.. (8/2/17). "Press Release: TCB Selected for EU Horizon 2020 Funding to Progress Novel, Mass-market Cell Therapies to Clinical Trial". Scotland.
Record changed: 2019-06-09


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for TC BioPharm Ltd. (TCB)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top